Tudor Investment Corp ET AL Purchases 50,514 Shares of Aveanna Healthcare Holdings Inc. (NASDAQ:AVAH)

Tudor Investment Corp ET AL grew its holdings in shares of Aveanna Healthcare Holdings Inc. (NASDAQ:AVAH) by 30.7% in the fourth quarter, according to its most recent disclosure with the Securities & Exchange Commission. The firm owned 214,978 shares of the company’s stock after purchasing an additional 50,514 shares during the quarter. Tudor Investment Corp ET AL’s holdings in Aveanna Healthcare were worth $982,000 at the end of the most recent reporting period.

Several other large investors have also recently modified their holdings of the business. First Eagle Investment Management LLC bought a new position in Aveanna Healthcare in the 4th quarter worth approximately $1,992,000. Swiss National Bank purchased a new stake in shares of Aveanna Healthcare during the fourth quarter worth $434,000. Federated Hermes Inc. boosted its holdings in shares of Aveanna Healthcare by 3,047.2% in the fourth quarter. Federated Hermes Inc. now owns 89,665 shares of the company’s stock worth $410,000 after acquiring an additional 86,816 shares during the period. JPMorgan Chase & Co. raised its stake in shares of Aveanna Healthcare by 80.5% during the 4th quarter. JPMorgan Chase & Co. now owns 154,703 shares of the company’s stock valued at $707,000 after purchasing an additional 68,989 shares during the period. Finally, Barclays PLC lifted its holdings in Aveanna Healthcare by 80.1% during the 3rd quarter. Barclays PLC now owns 122,689 shares of the company’s stock worth $637,000 after purchasing an additional 54,557 shares in the last quarter. Hedge funds and other institutional investors own 87.96% of the company’s stock.

Aveanna Healthcare Stock Up 1.1 %

Shares of NASDAQ AVAH opened at $4.79 on Wednesday. The firm has a market capitalization of $935.09 million, a P/E ratio of -14.10 and a beta of 2.01. The stock’s 50-day simple moving average is $4.77 and its two-hundred day simple moving average is $4.89. Aveanna Healthcare Holdings Inc. has a twelve month low of $2.31 and a twelve month high of $6.19.

Wall Street Analysts Forecast Growth

A number of research analysts have weighed in on AVAH shares. UBS Group lifted their target price on Aveanna Healthcare from $3.20 to $4.50 and gave the company a “sell” rating in a report on Friday, March 14th. Truist Financial reduced their price objective on shares of Aveanna Healthcare from $6.00 to $5.50 and set a “hold” rating for the company in a research note on Friday, April 11th.

Insider Buying and Selling

In related news, major shareholder J.H. Whitney Equity Partners V sold 5,580 shares of the stock in a transaction on Tuesday, April 1st. The stock was sold at an average price of $5.63, for a total value of $31,415.40. Following the transaction, the insider now owns 1,451,598 shares of the company’s stock, valued at $8,172,496.74. This represents a 0.38 % decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website. Over the last three months, insiders have sold 67,412 shares of company stock worth $372,142. Insiders own 7.80% of the company’s stock.

Aveanna Healthcare Profile

Aveanna Healthcare Holdings Inc, a diversified home care platform company, provides pediatric and adult healthcare services in the United States. Its patient-centered care delivery platform allows patients to remain in their homes and minimizes the overutilization of high-cost care settings, such as hospitals or skilled nursing facilities.